Cardiac Biomarkers Market Size, Share & Industry Analysis, By Indication (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, and Others), By Biomarker (Troponin, Creatine kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2026-2034

Last Updated: December 22, 2025 | Format: PDF | Report ID: FBI101233

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Cardiovascular Disorders, By Key Regions/ Key Countries, 2025
2. Overview of Impact of COVID-19 on the In-vitro Diagnostics Market
3. New Product Launches, By Key Market Players
4. Key Industry Developments such as Mergers and Acquisitions
5. Key Steps Taken by Companies, Government, etc. to Navigate the Impact of Covid-19
6. Overview: Impact of Covid-19 on Cardiac Tests
Global Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia pacific
  4. Latin America
  5. Middle East & Africa
North America Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2021)
3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, and Financials (based on availability))
  1. F. Hoffmann-La Roche AG
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  2. Abbott
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  3. Siemens AG
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  4. Creative Diagnostics
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  5. Beckman Coulter, Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  6. Bio-Rad Laboratories, Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  7. Thermo Fisher Scientific Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  8. bioMérieux SA
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  9. Other Prominent Players
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
Strategic Recommendations

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Cardiovascular Disorders, By Key Regions/ Key Countries, 2025
2. Overview of Impact of COVID-19 on the In-vitro Diagnostics Market
3. New Product Launches, By Key Market Players
4. Key Industry Developments such as Mergers and Acquisitions
5. Key Steps Taken by Companies, Government, etc. to Navigate the Impact of Covid-19
6. Overview: Impact of Covid-19 on Cardiac Tests
Global Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia pacific
  4. Latin America
  5. Middle East & Africa
North America Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Cardiac Biomarkers Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Indication
  1. Myocardial Infarction
  2. Congestive Heart Failure
  3. Acute Coronary Syndrome
  4. Others
3. Market Analysis, Insights and Forecast – By Biomarkers
  1. Troponin
  2. Creatine kinase-MB (CK-MB)
  3. B-type natriuretic peptide (BNP)
  4. Myoglobin
  5. Others
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Speciality Clinics
5. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2021)
3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, and Financials (based on availability))
  1. F. Hoffmann-La Roche AG
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  2. Abbott
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  3. Siemens AG
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  4. Creative Diagnostics
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  5. Beckman Coulter, Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  6. Bio-Rad Laboratories, Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  7. Thermo Fisher Scientific Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  8. bioMérieux SA
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  9. Other Prominent Players
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
Strategic Recommendations

Read Less

List of Figures

Figure 1: Global Cardiac Biomarkers Market Revenue Breakdown (USD Bn, %) by Region, 2025& 2034

Figure 2: Global Cardiac Biomarkers Market Value Share (%), by Indication, 2025& 2034

Figure 3: Global Cardiac Biomarkers Market Forecast (USD Bn), by Myocardial Infarction, 2021-2034

Figure 4: Global Cardiac Biomarkers Market Forecast (USD Bn), by Congestive Heart Failure, 2021-2034

Figure 5: Global Cardiac Biomarkers Market Forecast (USD Bn), by Acute Coronary Syndrome, 2021-2034

Figure 6: Global Cardiac Biomarkers Market Forecast (USD Bn), by Others, 2021-2034

Figure 7: Global Cardiac Biomarkers Market Value Share (%), by Biomarker, 2025& 2034

Figure 8: Global Cardiac Biomarkers Market Forecast (USD Bn), by Troponin, 2021-2034

Figure 9: Global Cardiac Biomarkers Market Forecast (USD Bn), by Creatine kinase-MB (CK-MB), 2021-2034

Figure 10: Global Cardiac Biomarkers Market Forecast (USD Bn), by B-type natriuretic peptide (BNP), 2021-2034

Figure 11: Global Cardiac Biomarkers Market Forecast (USD Bn), by Myoglobin, 2021-2034

Figure 12: Global Cardiac Biomarkers Market Forecast (USD Bn), by Others, 2021-2034

Figure 13: Global Cardiac Biomarkers Market Value Share (%), by End User, 2025& 2034

Figure 14: Global Cardiac Biomarkers Market Forecast (USD Bn), by Hospitals, 2021-2034

Figure 15: Global Cardiac Biomarkers Market Forecast (USD Bn), by Speciality Clinics, 2021-2034

Figure 16: Global Cardiac Biomarkers Market Value (USD Bn), by Region, 2025& 2034

Figure 17: North America Cardiac Biomarkers Market Value (USD Bn), by Indication, 2025& 2034

Figure 18: North America Cardiac Biomarkers Market Value Share (%), by Indication, 2025

Figure 19: North America Cardiac Biomarkers Market Value (USD Bn), by Biomarker, 2025& 2034

Figure 20: North America Cardiac Biomarkers Market Value Share (%), by Biomarker, 2025

Figure 21: North America Cardiac Biomarkers Market Value (USD Bn), by End User, 2025& 2034

Figure 22: North America Cardiac Biomarkers Market Value Share (%), by End User, 2025

Figure 23: North America Cardiac Biomarkers Market Value (USD Bn), By Country, 2025& 2034

Figure 24: North America Cardiac Biomarkers Market Value Share (%), By Country, 2025

Figure 25: Europe Cardiac Biomarkers Market Value (USD Bn), by Indication, 2025& 2034

Figure 26: Europe Cardiac Biomarkers Market Value Share (%), by Indication, 2025

Figure 27: Europe Cardiac Biomarkers Market Value (USD Bn), by Biomarker, 2025& 2034

Figure 28: Europe Cardiac Biomarkers Market Value Share (%), by Biomarker, 2025

Figure 29: Europe Cardiac Biomarkers Market Value (USD Bn), by End User, 2025& 2034

Figure 30: Europe Cardiac Biomarkers Market Value Share (%), by End User, 2025

Figure 31: Europe Cardiac Biomarkers Market Value (USD Bn), By Country/ Sub-region, 2025& 2034

Figure 32: Europe Cardiac Biomarkers Market Value Share (%), By Country/ Sub-region, 2025

Figure 33: Asia Pacific Cardiac Biomarkers Market Value (USD Bn), by Indication, 2025& 2034

Figure 34: Asia Pacific Cardiac Biomarkers Market Value Share (%), by Indication, 2025

Figure 35: Asia Pacific Cardiac Biomarkers Market Value (USD Bn), by Biomarker, 2025& 2034

Figure 36: Asia Pacific Cardiac Biomarkers Market Value Share (%), by Biomarker, 2025

Figure 37: Asia Pacific Cardiac Biomarkers Market Value (USD Bn), by End User, 2025& 2034

Figure 38: Asia Pacific Cardiac Biomarkers Market Value Share (%), by End User, 2025

Figure 39: Asia Pacific Cardiac Biomarkers Market Value (USD Bn), By Country/ Sub-region, 2025& 2034

Figure 40: Asia Pacific Cardiac Biomarkers Market Value Share (%), By Country/ Sub-region, 2025

Figure 41: Latin America Cardiac Biomarkers Market Value (USD Bn), by Indication, 2025& 2034

Figure 42: Latin America Cardiac Biomarkers Market Value Share (%), by Indication, 2025

Figure 43: Latin America Cardiac Biomarkers Market Value (USD Bn), by Biomarker, 2025& 2034

Figure 44: Latin America Cardiac Biomarkers Market Value Share (%), by Biomarker, 2025

Figure 45: Latin America Cardiac Biomarkers Market Value (USD Bn), by End User, 2025& 2034

Figure 46: Latin America Cardiac Biomarkers Market Value Share (%), by End User, 2025

Figure 47: Latin America Cardiac Biomarkers Market Value (USD Bn), By Country/ Sub-region, 2025& 2034

Figure 48: Latin America Cardiac Biomarkers Market Value Share (%), By Country/ Sub-region, 2025

Figure 49: Middle East & Africa Cardiac Biomarkers Market Value (USD Bn), by Indication, 2025& 2034

Figure 50: Middle East & Africa Cardiac Biomarkers Market Value Share (%), by Indication, 2025

Figure 51: Middle East & Africa Cardiac Biomarkers Market Value (USD Bn), by Biomarker, 2025& 2034

Figure 52: Middle East & Africa Cardiac Biomarkers Market Value Share (%), by Biomarker, 2025

Figure 53: Middle East & Africa Cardiac Biomarkers Market Value (USD Bn), by End User, 2025& 2034

Figure 54: Middle East & Africa Cardiac Biomarkers Market Value Share (%), by End User, 2025

Figure 55: Middle East & Africa Cardiac Biomarkers Market Value (USD Bn), By Country/ Sub-region, 2025& 2034

Figure 56: Middle East & Africa Cardiac Biomarkers Market Value Share (%), By Country/ Sub-region, 2025

Figure 57: Global Cardiac Biomarkers Market Share (%), By Company, 2025

List of Tables

Table 1: Global Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2021-2034

Table 2: Global Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2021-2034

Table 3: Global Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2021-2034

Table 4: Global Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Region, 2021-2034

Table 5: North America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2021-2034

Table 6: North America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2021-2034

Table 7: North America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2021-2034

Table 8: North America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, By Country, 2021-2034

Table 9: Europe Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2021-2034

Table 10: Europe Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2021-2034

Table 11: Europe Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2021-2034

Table 12: Europe Cardiac Biomarkers Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2021-2034

Table 13: Asia Pacific Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2021-2034

Table 14: Asia Pacific Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2021-2034

Table 15: Asia Pacific Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2021-2034

Table 16: Asia Pacific Cardiac Biomarkers Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2021-2034

Table 17: Latin America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2021-2034

Table 18: Latin America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2021-2034

Table 19: Latin America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2021-2034

Table 20: Latin America Cardiac Biomarkers Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2021-2034

Table 21: Middle East & Africa Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Indication, 2021-2034

Table 22: Middle East & Africa Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by Biomarker, 2021-2034

Table 23: Middle East & Africa Cardiac Biomarkers Market Revenue (USD Bn) Forecast, by End User, 2021-2034

Table 24: Middle East & Africa Cardiac Biomarkers Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 135

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com